Pharmaceutical Training Course Calendar

Back to details

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom 2023 2024
Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
A Practical Guide to Producing and Maintaining the PSMF Vigilance 19 24 5 10
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 18 16 1 9
Advanced Pharmacovigilance Vigilance 11-15 20-22 5-7 18-20
Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Leadership & Strategy 7-8 4-5 18-19
An Essential Overview of Medical Information Regulatory Affairs 15 11 29
An Essential Overview of Pharmacovigilance Vigilance 29 16 9-10
An Essential Overview of the Medical Device Industry Regulatory Affairs 1 8-9 8
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 19 10 13
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 24 10 23
An Introduction to Pharmaceutical Packaging GxP 30-1 20-22 25-27
Artificial Intelligence and Machine Learning Powered Signal Management Medical Technology 24 15 18
Best Practice for Writing Effective SOPs Regulatory Affairs 14 23 18
Biosimilars Biopharma 5-6 10-11 1-2
Biotechnology for the Non-Biotechnologist Biopharma 24-26 24-28 25-27
CAPA (Corrective and Preventative Action) Regulatory Affairs 22 19
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 29-1 27-28 17-18
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 7-8 19-20 2-3
Clinical Quality Management Systems Clinical Research 25-26 23-24 19-20
Clinical Research - A Different Approach to Successful Project Delivery Clinical Research 16 10 4
Clinical Trial Monitoring Clinical Research 29-30 11-12
Clinical Trial Regulatory Requirements Clinical Research 22-23 2-3 16-17
Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Clinical Research 20 18
Consultative Selling for Pharma Professionals Sales 15-16 13-14 17-18
Cosmetovigilance Vigilance 5-6 20-21 14-15
Data Integrity Auditor Master Class GxP 30-31 30-1 24-25 16-17
Data Integrity and Document Management GxP 12 22
Delivery of Biologics to the Nasal Cavity Biopharma 6 4 8
Development of Combination Products: Critical Interactions GxP 12-13 25-26 7-10
Drafting Commercial Contracts for the Pharmaceutical Industry Commercial Contracts 13-14 8-9 20-21
Drafting and Negotiating Clinical Trial Agreements Commercial Contracts 2 9 19 5
Drug Discovery: A Step-by-Step Introduction Medical Technology 25-26 9-10 19-20
EU Clinical Trial Regulation 536/2014: Overview and Implementation Experience Clinical Research 15-16 20-21 25-26 11-12
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 12-13 11-12 14-15
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 24 22 18
Effective Technical Writing & Editing Medical Writing 1 28 1
Effective Technology Transfer GxP 23-24 16-17 16-17 7-8
Effective Training Skills in the Pharma Industry Coaching & Mentoring 29-1 13-14 10-11
European Post Marketing Pharmacovigilance - Including the EMA/PRAC Deliberations and Brexit Implications Vigilance 4-8 15-17 4-8
Filing eCTD Submissions Regulatory Affairs 25 19
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 15 1 22
ICH Q9(R1) Quality Risk Management (QRM) GxP 31 1 25
In the Light of Annex 1: Use of Barrier Systems for Aseptic Pharmaceutical Manufacturing GxP 6
MBA Strategic Thinking for Pharma and Biopharma Professionals Leadership & Strategy 29-30 25-26 15-16 3-4
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Clinical Research 15-16 18-19 24-25 17-18
Metrics and Earned Value in Clinical Research Projects Clinical Research 6 11 25
Navigating China’s API Regulations: An Essential Guide to DMF Registration GxP 1
New EU GMP Annex 1: Compliant Aseptic Operations GxP 12-14 2-4 26-28
Pharmaceutical Development of ATMPs GxP 5-8 18-19 14-15
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 7-8 23-24 19-22
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 27-29 12-14 9-11
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 12-13 29-30 2-3
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 8-9 24-27 3-4
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 22-23 17-18
Pharmacovigilance Vigilance 31-2 12-14 9-11
Pharmacovigilance Aspects of Licensing Agreements Vigilance 1 10 27-28
Pharmacovigilance QMS & Inspection Preparation Vigilance 22-25 20-21 26-27
Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Vigilance 31-2 8-10 30-2
Positive Persuading and Influencing Skills for Pharma Professionals Management 18-19 29-30 11-12
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 13-14 13-14 17-18
Process Validation with Qualification GxP 16-17 21-22 23-24
Project Management for Pharma Professionals Project Management 11-12 17-18 26-27
Regulatory Affairs for Support Staff Regulatory Affairs 29-30 13-14 24-25
Regulatory Strategies for Orphan Drugs Regulatory Affairs 15 24 8
Risk Management for Pharma and Biopharma Professionals Regulatory Affairs 2 7 8
Robotics and Digitalization in Aseptic Pharmaceutical Manufacturing GxP 14
Root Cause Analysis and Critical Thinking Management 22 23 25
Signal Detection and Regulatory Expectations Vigilance 18-19 1-2 12-15
Smart Packaging and Electronic Patient Information GxP 14 10 4-5
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 4-7 11-12 11-12
Successful Medical Writing – from Protocol to CTD Medical Writing 20-22 24-26 27-29
The Common Technical Document GxP 12-13 2-3 25-26
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 14 10 28
The FDA Drug Approval Process Regulatory Affairs 6-7 12-13 14-15
The Leadership and Management Summer School for Pharma Professionals Leadership & Strategy 29-2
The Pharma Mini MBA Leadership & Strategy 7-9 15-17 31-2 6-8
US FDA - Understanding Key Factors When Working with the FDA Biopharma 19 18 19
Understanding Active Pharmaceutical Ingredients (APIs) - A Comprehensive and Practical Introduction GxP 13-14 17-18 18-19
Understanding Computer System Validation (CSV) - A Comprehensive and Practical Introduction GxP 19-20 24-25 25-26
Understanding Pharmacovigilance Regulations in APAC Vigilance 23-24 23-24 8-9 8-9
Variations to Marketing Authorisations Regulatory Affairs 1-2 4-5 10-11
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Leadership & Strategy 12 21 14